Interventional Oncology Market to Be Worth $1,506.3 Million by 2025- Exclusive Report by Meticulous Research®

LONDON, August 23, 2019 (Newswire.com) - ​Meticulous Research^®, has published a latest market research report on highly intriguing industry segment, “Interventional Oncology” in past week. The report states that global Interventional Oncology market will increase at a CAGR of 7.7% from 2019 to reach $1,506.3 Million by 2025, driven by rising incidence &prevalence of cancer, increase in cancer related mortality, technological advancements in the field of radiology, rising reimbursement coverage for the interventional oncology products, and rising number of hospitals across the globe.

Please download the report and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4951

The report provides meticulous analysis of this market by segmenting it on the basis of procedure (tumor embolization and tumor ablation), product [tumor embolization (radioembolic agents and non-radioactive agents), tumor ablation (microspheres, drug eluting beads, and particles)], application (liver, lung, breast, prostate, kidney, bone metastasis, others), end user (hospitals, ambulatory surgical centers, and research & academia), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to the Presence of well-established healthcare system including hospitals and ASCs in the North American region, greater adoption of advanced technologies, high level of awareness and spending towards healthcare, growing incidence and prevalence of cancer, and high level of Medicare & Medicaid health insurance coverage.

On the other hand “Emerging countries in Asia and Latin America offer high growth opportunities due to increasing aging population suffering from non-communicable diseases such as cancer, growing income levels and penetration of health insurance, and rising focus of key vendors in these regions!” said Uddhav Sable, Research Director at Meticulous Research^®

Among applications, liver cancer segment commanded the largest share in this market. The largest share of this segment is primarily attributed to availability of wide range of embolization and ablation products globally for liver cancer treatment and growing prevalence of the disease and related mortality.

The key players analyzed in the global Interventional Oncology market are Sirtex Medical Limited, BTG plc, Medtronic plc, Boston Scientific Corporation, AngioDynamics, Inc., C. R. Bard, Inc., Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.

The report is available for purchase in electronic format with multiple license choices and sectional purchases, starting from $499 only.

Request Sample or Check for Discount: https://www.meticulousresearch.com/request-discount/cp_id=4951

Scope of the Report:

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Secondary Research
    2.2. Primary Research

3. Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Growing Preference for Minimally invasive Treatment Procedures
                     4.2.1.2. Increasing Incidence & Prevalence of Cancer
                     4.2.1.3. Rising Number of Hospitals
                     4.2.1.4. Technological Advancements in the Field of Radiology
           4.2.2. Restraints
                     4.2.2.1. Potential Risks Associated with Interventional Oncology Procedures
                     4.2.2.2. High Cost Associated with Interventional Oncology Procedures
                     4.2.2.3. Paucity of Skilled Healthcare Professionals
           4.2.3. Opportunities
                     4.2.3.1. Significant Growth Opportunities from Emerging Asian and Latin American Markets
                     4.2.3.2. Introduction of Cloud-Based Medical Imaging
           4.2.4. Trend
                     4.2.4.1. Growing Integration of Image-Guided Solutions with Interventional Oncology Procedures

5. Interventional Oncology Market, by Procedure
    5.1. Introduction
    5.2. Tumor Embolization
           5.2.1. Transarterial Radioembolization (TARE)
           5.2.2. Transarterial Chemoembolization (TACE)
           5.2.3. Bland Embolization
    5.3. Tumor Ablation
           5.3.1. Thermal Ablation
                     5.3.1.1. Radiofrequency Ablation (RFA)
                     5.3.1.2. Microwave Ablation (MWA)
                     5.3.1.3. Cryoablation
                     5.3.1.4. Other Thermal Ablation Procedures
           5.3.2. Non-Thermal Ablation

6. Interventional Oncology Market, by Product
    6.1. Introduction
    6.2. Tumor Embolization
           6.2.1. Radioembolic Agents
                     6.2.1.1. Sir-Spheres
                     6.2.1.2. TheraSphere
                     6.2.1.3. QuiremSpheres
           6.2.2. Non-Radioactive Embolic Agents
                     6.2.2.1. Microspheres
                     6.2.2.2. Particles (PVA Particles and Gelfoam Particles)
                     6.2.2.3. Drug-Eluting Beads (DEBs)
    6.3. Tumor Ablation
           6.3.1. Tumor Ablation Devices/Generators
           6.3.2. Consumables & Accessories

7. Interventional Oncology Market, by Application
    7.1. Introduction
    7.2. Liver Cancer
    7.3. Lung Cancer
    7.4. Breast Cancer
    7.5. Prostate Cancer
    7.6. Kidney Cancer
    7.7. Bone Metastasis
    7.8. Other Cancers

8. Interventional Oncology Market, by End User
    8.1. Introduction
    8.2. Hospitals
    8.3. Ambulatory Surgery Centres
    8.4. Research and Academia

9. Interventional Oncology Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia-Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Rest of World
           9.5.1. Latin America
           9.5.2. Middle East & Africa

10. Competitive Landscape
      10.1. Growth Strategies
      10.2. Competitive Benchmarking
      10.3. Market Share Analysis (2018)

11. Company Profiles(Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
      11.1. Boston Scientific Corporation
      11.2. Cook Medical LLC (A Subsidiary of Cook Group)
      11.3. Merit Medical Systems, Inc.
      11.4. C. R. Bard, Inc. (A Subsidiary of Becton Dickinson & Company)
      11.5. Profound Medical Corp.
      11.6. AngioDynamics, Inc.
      11.7. BTG plc
      11.8. Terumo Corporation
      11.9. Medtronic plc
      11.10. Healthtronics, Inc.
      11.11. EDAP TMS S.A.
      11.12. Neuwave Medical, Inc. (Subsidiary of Ethicon Inc.)
      11.13. Sirtex Medical Limited
      11.14. Trod Medical
      11.15. Teleflex Incorporated
      11.16. IMBiotechnologies Ltd.

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

Please download the report and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4951

Source: Meticulous Market Research Pvt. Ltd.